Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
43.1M
-
Number of holders
-
66
-
Total 13F shares, excl. options
-
27M
-
Shares change
-
+417K
-
Total reported value, excl. options
-
$708M
-
Value change
-
+$8.75M
-
Put/Call ratio
-
1.01
-
Number of buys
-
32
-
Number of sells
-
-29
-
Price
-
$26.24
Significant Holders of Repare Therapeutics Inc. - Common Shares, no par value (RPTX) as of Q3 2021
77 filings reported holding RPTX - Repare Therapeutics Inc. - Common Shares, no par value as of Q3 2021.
Repare Therapeutics Inc. - Common Shares, no par value (RPTX) has 66 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 27M shares
of 43.1M outstanding shares and own 62.61% of the company stock.
Largest 10 shareholders include BVF INC/IL (3.72M shares), ORBIMED ADVISORS LLC (3.32M shares), ARK Investment Management LLC (2.97M shares), FMR LLC (2.78M shares), Redmile Group, LLC (2.57M shares), MPM ASSET MANAGEMENT LLC (2.24M shares), CHI Advisors LLC (2.23M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.92M shares), BioImpact Capital LLC (1.64M shares), and Artal Group S.A. (550K shares).
This table shows the top 66 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.